CN102526354B - 一种用于病毒性疾病的中药 - Google Patents
一种用于病毒性疾病的中药 Download PDFInfo
- Publication number
- CN102526354B CN102526354B CN201210007168.6A CN201210007168A CN102526354B CN 102526354 B CN102526354 B CN 102526354B CN 201210007168 A CN201210007168 A CN 201210007168A CN 102526354 B CN102526354 B CN 102526354B
- Authority
- CN
- China
- Prior art keywords
- radix
- ethanol
- hour
- carry out
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 201000010099 disease Diseases 0.000 title claims abstract description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 29
- 230000003612 virological effect Effects 0.000 title claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 241000628997 Flos Species 0.000 claims description 15
- 239000010231 banlangen Substances 0.000 claims description 14
- 239000009806 pulsatillae Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 238000003809 water extraction Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 210000002421 cell wall Anatomy 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 238000000498 ball milling Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 10
- 206010064097 avian influenza Diseases 0.000 abstract description 7
- 230000002458 infectious effect Effects 0.000 abstract description 7
- 208000011580 syndromic disease Diseases 0.000 abstract description 6
- 208000027312 Bursal disease Diseases 0.000 abstract description 4
- 208000002979 Influenza in Birds Diseases 0.000 abstract description 4
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 4
- 235000012550 Pimpinella anisum Nutrition 0.000 abstract description 4
- 206010003274 Arthritis viral Diseases 0.000 abstract description 3
- 208000004575 Infectious Arthritis Diseases 0.000 abstract description 3
- 208000006758 Marek Disease Diseases 0.000 abstract description 3
- 206010006451 bronchitis Diseases 0.000 abstract description 3
- 241000271566 Aves Species 0.000 abstract description 2
- 240000003870 Ageratum houstonianum Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 208000010359 Newcastle Disease Diseases 0.000 abstract 1
- 240000004760 Pimpinella anisum Species 0.000 abstract 1
- 241000206469 Pulsatilla Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 208000037824 growth disorder Diseases 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 description 23
- 235000013330 chicken meat Nutrition 0.000 description 22
- 208000024891 symptom Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 235000021050 feed intake Nutrition 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 210000003128 head Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000000051 wattle Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 240000009023 Myrrhis odorata Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 210000003746 feather Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229930190011 Bufogenin Natural products 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010058314 Dysplasia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 208000004668 avian leukosis Diseases 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- ATLJNLYIJOCWJE-CWMZOUAVSA-N bufogenin Chemical compound C=1([C@H]2C[C@H]3O[C@@]43[C@H]3[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC3)C)CC[C@@]42C)C=CC(=O)OC=1 ATLJNLYIJOCWJE-CWMZOUAVSA-N 0.000 description 2
- 229950006858 bufogenin Drugs 0.000 description 2
- 210000001669 bursa of fabricius Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000003739 neck Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 210000002976 pectoralis muscle Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- HDTHCLKLBSPBIS-JBXNKDOXSA-N (2s)-2-[[8-[[(3s,5r,8r,9s,10s,13r,14s,16s,17r)-16-acetyloxy-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-8-oxooctanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C=1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@@H](C[C@H]5CC[C@H]4[C@@]3(O)C[C@@H]2OC(=O)C)OC(=O)CCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C=CC(=O)OC=1 HDTHCLKLBSPBIS-JBXNKDOXSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- HDTHCLKLBSPBIS-UHFFFAOYSA-N Bufotoxin Natural products CC(=O)OC1CC2(O)C3CCC4CC(OC(=O)CCCCCCC(=O)NC(CCCN=C(N)N)C(O)=O)CCC4(C)C3CCC2(C)C1C=1C=CC(=O)OC=1 HDTHCLKLBSPBIS-UHFFFAOYSA-N 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010048469 Kidney enlargement Diseases 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010052535 Small intestinal haemorrhage Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 208000027685 extreme exhaustion Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010809 targeting technique Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了一种用于病毒性疾病的中药，它由以下重量份数的原料制成：蟾衣5~10、八角25~35、藿香10~15、金银花10~15、蒲公英15~20、白头翁20~25、大青叶25~30、板蓝根10~15、柴胡8~13。本发明用于禽流感、亚型禽流感、鸡马立克病、新城疫、禽白血病、传然性法氏囊病、传染性支气管炎、病毒性关节炎、减蛋综合症、传染性发育障碍综合症等多种病毒性疾病。
Description
技术领域
本发明涉及一种用于病毒性疾病的中药。
背景技术
从疫病监测情况看，近年来，国内外禽流感、压型禽流感、鸡马立克病、新城疫、禽白血病、传然性法氏囊病、传染性支气管炎、病毒性关节炎、减蛋综合症、传染性发育障碍综合症等病毒性疾病，病原体变异和混合感染的现象较为普遍，发生频次偏高，有些病还呈现地方性流行的特点，导致疾病的临床表现比较复杂，所以对多种病毒性疾病的防控迫在眉睫。
发明内容
本发明要解决的技术问题是提供一种用于病毒性疾病的中药。
本发明的技术方案是：一种用于病毒性疾病的中药，它由以下重量份数的原料制成：蟾衣5~10、八角25~35、藿香10~15、金银花10~15、蒲公英15~20、白头翁20~25、大青叶25~30、板蓝根10~15、柴胡8~13。
用于病毒性疾病的中药优选由以下重量份数的原料制成：蟾衣6~8、八角28~32、藿香12~14、金银花12~14、蒲公英16~18、白头翁22~24、大青叶26~28、板蓝根12~14、柴胡10~12。
用于病毒性疾病的中药最优由以下重量份数的原料制成：蟾衣7、八角30、藿香13、金银花13、蒲公英17、白头翁23、大青叶27、板蓝根13、柴胡11。
用于病毒性疾病的中药，它还包括以下重量份数的辅料：车前子10~14、黄芩8~10、苏叶25~30、甘草15~20、陈皮15~20、杏仁6~10、连翘10~12、桑叶20~26。
上述中药可以传统熬制，也可以按如下方法：
a、将各成分按重量份称取，分别采用超微粉碎和细胞壁破壁技术，进行初步处理，超微粉是粉碎粒度95%达到粒径在5~~10UM，所用机械冲击式粉碎机、气流式粉碎机、球磨式粉碎机；
b、将a步处理好的各成分分别进行水提取，首先浸泡1-2小时，用水量以浸没原材料为准，再用热回流提取5-8小时，之后进行过滤，取滤液浓缩至原浸出液的1/100，变成流浸膏状；
c、再次分别对水提取过的药渣再进行2次低温醇沉提取，首先在药渣里加入3-5倍体积比的80%乙醇进行低温醇沉12-24小时，然后再加入3-5倍体积比的95%乙醇进行低温醇沉12-24小时，过滤去残渣，滤液进行减压回收乙醇；
d、合并步骤b、c所制备出的两种提取液，用纯水稀释至处方量的1g/ml，加入防腐剂和抗氧化剂混匀后灭菌，4℃保存备用。
药物的用法及用量：
每100克药兑水600kg自由饮用；或每100克拌料300kg连用3-5天。也可根据病情酌情增减或遵医嘱。
蟾衣中所含蟾毒内酯、蟾毒素：其成分是可抑制和消灭癌肿细胞，能够阻止癌肿细胞复发，蟾毒内酯是蟾衣中独有的物质，是抑制病毒扩散的重要物质。八角功效：散寒，理气，止痛，水煎剂对人型结核杆菌及枯草杆菌有抑菌作用。藿香味辛；性微温。归肺；脾；胃经。祛暑解表；化湿和胃。用于夏令感冒；寒热头痛；胸脘痞闷；呕吐泄泻；妊娠呕吐；鼻渊；手；足癣。金银花自古被誉为清热解毒的良药。它性甘寒气芳香，甘寒清热而不伤胃，芳香透达又可祛邪。金银花既能宣散风热，还善清解血毒，用于各种热性病，如身热、发疹、发斑、热毒疮痈、咽喉肿痛等证，均效果显著。蒲公英甘，微苦，寒。清热解毒，消肿散结。白头翁味苦，性寒；归胃、大肠经，具有清热解毒，凉血止痢，燥湿杀虫的功效，主治热毒痢疾，鼻衄，血痔，带下，阴痒，痈疮，瘰疬。大青叶苦，寒。味甘。入肝、心、胃经。板蓝根具有清热解毒、凉血消肿、利咽之功效。柴胡是清虚热中药，用于感冒发热、寒热往来、疟疾。车前子性味甘寒，入肾、膀胱、肝、肺经，功能利水通淋、渗湿止泻、清肝明目、清热化痰，为常用药材。黄芩有清热燥湿，凉血安胎，解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。苏叶用于感冒风寒，发热恶寒，头痛鼻塞，兼见咳嗽或胸闷不舒者。能发散表寒，开宣肺气，可与生姜同用。甘草气微，味甜而特殊。功能主治清热解毒，祛痰止咳、脘腹。陈皮气香，味辛、苦。理气开胃 燥湿化痰，治脾胃病。杏仁归经：肺；脾；大肠经。具有抗炎、镇痛作用。连翘是清热解毒的中药，主治热病初起，风热感冒，发热，心烦，咽喉肿痛，急性肾炎等。桑叶味甘，苦；性寒。归肺，肝经。疏散风热，清肺润燥，平抑肝阳，清肝明目，凉血止血。
本发明的有益效果是：用于禽流感、亚型禽流感、鸡马立克病、新城疫、禽白血病、传然性法氏囊病、传染性支气管炎、病毒性关节炎、减蛋综合症、传染性发育障碍综合症等多种病毒性疾病。采用控释和靶向技术，使药物能直接到达病灶部位，并延长有效时间，增强中草药的疗效。采用超微粉碎和细胞壁破壁技术，使药物的有效成分快速发挥，同时采用二氧化碳超低温临界单体萃取技术，使药物有效成分不被破坏且提取完全，保证有效成分充足，药效增加。保障产品的核心技术，保证产品的质量和疗效。采用先进的指纹图谱鉴定技术，保证所选中药材的质地为优等级。
1本发明药效发挥迅速，副作用小，治疗时间短，使用方便。
本中草药经超微粉碎和细胞壁破壁技术、水提、醇沉后，所获得的流浸膏，直接饮水而不堵塞饮水器，据临床试验证明，自投药后24小时观察，鸡群采食量和精神有明显好转，48小时后死亡率有所下降，72小时后采食量和精神基本恢复正常，且解剖后内脏器官的病变发生率比对照组低75-90%。如下表：
| 观察项目 | 鸡只数 | 24小时采食量 | 48小时采食量 | 症状 |
| 实验组 | 2400 | 385斤 | 480斤 | 118只 |
| 对照组 | 2400 | 302斤 | 255斤 | 943只 |
症状为表现为流感特征的内脏器官病变
| 观察项目 | 鸡只数 | 24小时采食量 | 48小时采食量 | 法氏囊病变发生率 |
| 实验组 | 2400 | 380斤 | 460斤 | 102只 |
| 对照组 | 2400 | 298斤 | 265斤 | 856只 |
2发挥作用持续时间长，血药浓度高，药效持久。
经比较：正常中草药在消化系统停留2-6小时，而经该技术处理后，在禽类消化系统的有效时间为8-12小时，大大延长了肠道内的停留时间，吸收利用率显著增加，经比较，普通中药（40-60目）在肠道内随粪便排出后能检测到大量的中药原型，而本实验品在经粪便排出后，几乎检不出。同时MIC也明显不一，本实验品比普通中药高90%。
3针对性强，治愈率高，保护率高。
投服本实验品和投服普通中药的肉鸡，经饲喂4天后，明显出现差异，如下表：
| 观察项目 | 鸡只数 | 精神和采食量 | 有呼吸道症状比率 | 继发感染大肠杆菌数 | 每天死亡数 | 淘汰只数 |
| 实验组 | 2400 | 正常 | 15-25% | 18只 | 5-8 | 108 |
| 对照组 | 2400 | 下降 | 80-95% | 93只 | 18-29 | 456 |
| 观察项目 | 鸡只数 | 精神和采食量 | 有传染性法氏囊炎症状比率 | 继发感染大肠杆菌数 | 每天死亡数 | 淘汰只数 |
| 实验组 | 2400 | 正常 | 10-15% | 24只 | 3-8 | 112 |
| 对照组 | 2400 | 下降 | 65-85% | 96只 | 25-30 | 516 |
具体实施方式
实施例1
一种用于病毒性疾病的中药，配方：蟾衣5kg、八角25 kg、藿香10 kg、金银花10 kg、蒲公英15 kg、白头翁20 kg、大青叶25 kg、板蓝根10 kg、柴胡8 kg。
实施例2
一种用于病毒性疾病的中药，配方：蟾衣10kg、八角35 kg、藿香15 kg、金银花15 kg、蒲公英20 kg、白头翁25 kg、大青叶30 kg、板蓝根15 kg、柴胡13 kg。
实施例3
一种用于病毒性疾病的中药，配方：蟾衣6kg、八角28 kg、藿香12 kg、金银花12 kg、蒲公英16 kg、白头翁22 kg、大青叶26 kg、板蓝根12 kg、柴胡10 kg。
实施例4
一种用于病毒性疾病的中药，配方：蟾衣8kg、八角32 kg、藿香14 kg、金银花14 kg、蒲公英18 kg、白头翁24 kg、大青叶28 kg、板蓝根14 kg、柴胡12 kg。
实施例5
一种用于病毒性疾病，配方：蟾衣7 kg、八角30 kg、藿香13 kg、金银花13 kg、蒲公英17 kg、白头翁23 kg、大青叶27 kg、板蓝根13 kg、柴胡11 kg，车前子14 kg、黄芩10 kg、苏叶30 kg、甘草20 kg、陈皮20 kg、杏仁10 kg、连翘12 kg、桑叶26 kg。
实施例6
一种用于病毒性疾病，配方：蟾衣7 kg、八角30 kg、藿香13 kg、金银花13 kg、蒲公英17 kg、白头翁23 kg、大青叶27 kg、板蓝根13 kg、柴胡11 kg，车前子10 kg、黄芩8 kg、苏叶25 kg、甘草15 kg、陈皮15 kg、杏仁6 kg、连翘10 kg、桑叶20 kg。
中药组合物临床疗效的典型病例
实例一：山东潍坊某养殖场35日龄雏鸡、约1800只鸡发病，病禽表现为突然发病，体温升高，可达42℃以上。精神沉郁，肿头，眼睑周围浮肿，肉冠和肉垂肿胀、出血甚至坏死，鸡冠发紫。采食量急剧下降。病禽呼吸困难、咳嗽、打喷嚏，张口呼吸，突然尖叫。眼肿胀流泪，初期流浆液性带泡沫的眼泪，后期流黄白色脓性分泌物，眼睑肿胀，两眼突出，肉髯增厚变硬，向两侧开张，呈“金鱼头”状。也有的出现抽搐，头颈后扭，运动失调，瘫痪等神经症状。经病死鸡剖检可见口腔、腺胃、肌胃角质下层和十二指肠出血；胸骨内面、胸骨肌肉、腹部脂肪和心均有散在出血点；头、眼睑、肉髯、颈、胸等部分肿胀，组织呈淡黄色；肝、脾、肾、肺常见灰黄色小点坏死灶；腹膜和心包或有充血和积液；卵巢和输卵管充血或出血，管壁肿胀。经诊断为禽流感感染。应用本发明制备的中药组合物进行治疗，采用饮水给药的方式集中给药，严重的经肌肉注射给药，治疗前后对圈舍进行严格消毒处理。用药3天后，病鸡的临床症状及精神状态明显好转，用药7天后，1756只病鸡恢复健康，临床症状消失，治愈率达到97.6%，治愈一个月后进行回访，康复的病鸡没有再复发。
实例二：哈尔滨某养殖场32日龄雏鸡、约1300只鸡发病，病鸡精神沉郁，食欲减退，不喜走路，羽毛松乱无光泽，垂头缩颈，冠和肉髯发绪，眼半闭，有的病鸡出现神经症状，两腿麻痹、站立不稳，经诊断为新城疫感染。应用本发明制备的中药组合物进行治疗，采用饮水给药的方式集中给药，严重的经肌肉注射给药，治疗前后对圈舍进行严格消毒处理。用药3天后，病鸡的临床症状及精神状态明显好转，用药5天后，1237只病鸡恢复健康，临床症状消失，治愈率达到95.2%，治愈一个月后进行回访，康复的病鸡没有再复发。
实例三：河南某个体养殖户13日龄雏鸡、约1400只鸡发病，病鸡下痢，排浅白色或淡绿色稀粪，腹泻物中常含有尿酸盐，肛门周围的羽毛被粪污染或沾污泥土。随着病程的发展，饮、食欲减退，并逐渐消瘦、畏寒，颈部躯干震颤，步态不稳，行走摇摆，体温正常或在疾病末期体温低于正常，精神萎顿，头下垂眼睑闭合，羽毛无光泽，蓬松脱水，眼窝凹陷，最后极度衰竭而死。死于感染的鸡呈现脱水、胸肌发暗，股部和胸肌常有出血斑、点，肠道内粘液增加，肾脏肿大、苍白，小叶灰白色，有尿酸盐沉积，法氏囊出现肿大，经诊断为传染性法氏囊炎感染。应用本发明制备的中药组合物进行治疗，采用饮水给药的方式集中给药，严重的肌肉注射给药，治疗前后对鸡舍及周围环境进行严格消毒。用药2天后鸡群病情好转，用药5天后，1365只病鸡恢复健康，临床症状消失，治愈率达到97.5%，治愈后一个月回访，康复鸡群没有再发病。
Claims (4)
1.一种用于病毒性疾病的中药，其特征在于它由以下重量份数的原料制成：蟾衣5~10、八角25~35、藿香10~15、金银花10~15、蒲公英15~20、白头翁20~25、大青叶25~30、板蓝根10~15、柴胡8~13，按如下方法熬制：
a、将各成分按重量份称取，分别采用超微粉碎和细胞壁破壁技术，进行初步处理，超微粉是粉碎粒度95%达到粒径在5~10 μm，所用设备为机械冲击式粉碎机、气流式粉碎机、球磨式粉碎机；
b、将a步处理好的各成分分别进行水提取，首先浸泡1-2小时，用水量以浸没原材料为准，再用热回流提取5-8小时，之后进行过滤，取滤液浓缩至原浸出液的1/100，变成流浸膏状；
c、再分别对水提取过的药渣再进行2次低温醇沉提取，首先在药渣里加入3-5倍体积比的80%乙醇进行低温醇沉12-24小时，然后再加入3-5倍体积比的95%乙醇进行低温醇沉12-24小时，过滤去残渣，滤液减压回收乙醇；
d、合并步骤b、c所制备出的两种提取液，用纯水稀释至处方量的1g/ml，加入防腐剂和抗氧化剂混匀后灭菌，4℃保存备用。
2.根据权利要求1所述的用于病毒性疾病的中药，其特征在于它由以下重量份数的原料制成：蟾衣6~8、八角28~32、藿香12~14、金银花12~14、蒲公英16~18、白头翁22~24、大青叶26~28、板蓝根12~14、柴胡10~12。
3.根据权利要求2所述的用于病毒性疾病的中药，其特征在于它由以下重量份数的原料制成：蟾衣7、八角30、藿香13、金银花13、蒲公英17、白头翁23、大青叶27、板蓝根13、柴胡11。
4.一种用于病毒性疾病的中药，其特征在于它由以下重量份数的原料制成：蟾衣7、八角30、藿香13、金银花13、蒲公英17、白头翁23、大青叶27、板蓝根13、柴胡11、车前子10~14、黄芩8~10、苏叶25~30、甘草15~20、陈皮15~20、杏仁6~10、连翘10~12、桑叶20~26，按如下方法熬制：
a、将各成分按重量份称取，分别采用超微粉碎和细胞壁破壁技术，进行初步处理，超微粉是粉碎粒度95%达到粒径在5~10 μm，所用设备为机械冲击式粉碎机、气流式粉碎机、球磨式粉碎机；
b、将a步处理好的各成分分别进行水提取，首先浸泡1-2小时，用水量以浸没原材料为准，再用热回流提取5-8小时，之后进行过滤，取滤液浓缩至原浸出液的1/100，变成流浸膏状；
c、再分别对水提取过的药渣再进行2次低温醇沉提取，首先在药渣里加入3-5倍体积比的80%乙醇进行低温醇沉12-24小时，然后再加入3-5倍体积比的95%乙醇进行低温醇沉12-24小时，过滤去残渣，滤液减压回收乙醇；
d、合并步骤b、c所制备出的两种提取液，用纯水稀释至处方量的1g/ml，加入防腐剂和抗氧化剂混匀后灭菌，4℃保存备用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210007168.6A CN102526354B (zh) | 2012-01-11 | 2012-01-11 | 一种用于病毒性疾病的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210007168.6A CN102526354B (zh) | 2012-01-11 | 2012-01-11 | 一种用于病毒性疾病的中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526354A CN102526354A (zh) | 2012-07-04 |
| CN102526354B true CN102526354B (zh) | 2014-05-07 |
Family
ID=46335174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210007168.6A Active CN102526354B (zh) | 2012-01-11 | 2012-01-11 | 一种用于病毒性疾病的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526354B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393891B (zh) * | 2013-08-09 | 2015-07-22 | 烟台绿叶动物保健品有限公司 | 一种抗病毒兽用复方中药及其制备方法和用途 |
| CN104524154A (zh) * | 2014-12-29 | 2015-04-22 | 河南天纳图生物科技有限公司 | 一种用于畜禽止咳平喘的复合发酵型中药及其制备方法 |
| CN106109786B (zh) * | 2016-06-30 | 2021-05-11 | 容县祥益农牧有限公司 | 一种治疗禽流感、支气管炎的组合物、制备方法及应用 |
| CN111067988A (zh) * | 2020-01-14 | 2020-04-28 | 云南西草资源开发有限公司 | 一种预防禽流感的中药制剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879814B (zh) * | 2006-05-16 | 2010-09-08 | 天津生机集团有限公司 | 禽用抗病毒药物及其制备方法 |
| CN101411804B (zh) * | 2007-10-19 | 2011-06-29 | 鞍山钢铁集团公司 | 一种清肺合剂及其制备方法 |
| CN101422539A (zh) * | 2007-11-02 | 2009-05-06 | 天津瑞普生物技术集团有限公司 | 一种用于治疗畜禽病毒细菌混合感染的中药口服液 |
| KR20100123299A (ko) * | 2009-05-15 | 2010-11-24 | 정대희 | 암 치료제. |
| US20110250259A1 (en) * | 2010-04-12 | 2011-10-13 | Kevin Buckman | Method of treating and preventing breast diseases and breast cancer with medicated formula |
-
2012
- 2012-01-11 CN CN201210007168.6A patent/CN102526354B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526354A (zh) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102552502B (zh) | 一种用于禽细菌性疾病的中药 | |
| CN102526354B (zh) | 一种用于病毒性疾病的中药 | |
| CN104523943A (zh) | 一种防治畜禽多种瘟病的复方发酵型中药 | |
| CN1251732C (zh) | 一种治疗肺内感染的中药 | |
| CN104147572A (zh) | 感冒发热疏风散热制剂及制备方法 | |
| CN106309877A (zh) | 防治猪凝血性脑脊髓炎病毒的药物 | |
| CN103585401A (zh) | 一种治疗禽流感的中药组合物及其制备方法 | |
| CN103494927B (zh) | 一种用于治疗鸡呼吸道疾病的中药组合物及其制备方法 | |
| CN102698158B (zh) | 防治鸡肾型传染性支气管炎的中药、制备方法和饲料 | |
| CN104147574A (zh) | 治疗感冒发烧的清热解表中药组合物及制备方法 | |
| CN102552417B (zh) | 一种用于禽呼吸道疾病的中药 | |
| CN103656145B (zh) | 用于治疗猪肺疫的药物及其制备方法 | |
| CN104825972A (zh) | 一种防治畜禽瘟疫的醋浸中药超微粉制剂 | |
| CN102228607B (zh) | 一种用于治疗猪无名高热病的口服液 | |
| CN103142702A (zh) | 治疗猪蓝耳病的中草药注射液及其制备方法 | |
| CN103341151B (zh) | 用于治疗慢性支气管炎的中药 | |
| CN103393891B (zh) | 一种抗病毒兽用复方中药及其制备方法和用途 | |
| CN106039074A (zh) | 治疗犬细小病毒的药片 | |
| CN105994984A (zh) | 一种防治禽流感的中药饲料添加剂 | |
| CN108524746A (zh) | 一种防治家禽感冒的中药组合物 | |
| CN103041084A (zh) | 治疗猪瘟的药物 | |
| CN106344876A (zh) | 一种防治畜禽呼吸道疾病的中药组合物及其制备方法 | |
| CN105727036A (zh) | 一种用于防治鸡马立克氏病的中药组合物及其制备方法 | |
| CN105126091A (zh) | 猪高热病的防治方法 | |
| CN104435864A (zh) | 一种用于鸡原虫病的复方发酵型中药及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicament for viral diseases Effective date of registration: 20170905 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd Luohe branch Pledgor: Henan Tanatu Biotechnology Co.,Ltd. Registration number: 2017990000828 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181012 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd Luohe branch Pledgor: Henan Tanatu Biotechnology Co.,Ltd. Registration number: 2017990000828 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicament for viral diseases Effective date of registration: 20181012 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd Luohe branch Pledgor: Henan Tanatu Biotechnology Co.,Ltd. Registration number: 2018990000952 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191015 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd Luohe branch Pledgor: Henan Tanatu Biotechnology Co.,Ltd. Registration number: 2018990000952 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicament for viral diseases Effective date of registration: 20191015 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd Luohe branch Pledgor: Henan Tanatu Biotechnology Co.,Ltd. Registration number: Y2019990000332 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201021 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd. Luohe branch Pledgor: HENAN TANATU BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2019990000332 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine for viral diseases Effective date of registration: 20201027 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd. Luohe branch Pledgor: HENAN TANATU BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2020980007180 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211019 Granted publication date: 20140507 Pledgee: Bank of China Limited by Share Ltd. Luohe branch Pledgor: HENAN TANATU BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2020980007180 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |